Evidence map›Paper›PMID 27447370›Full record

ArticleJournal of cardiovascular electrophysiology2016

Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.

Irina A Polejaeva, Ravi Ranjan, Christopher J Davies, Misha Regouski, Justin Hall, Aaron L Olsen, Qinggang Meng, Heloisa M Rutigliano, Derek J Dosdall, Nathan A Angel and 12 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Time's imprint on the left atrium: aging and atrial myopathy.The journal of cardiovascular aging · 2025
    Article
  6. Article
  7. Review
  8. Gene therapy for atrial fibrillation.Journal of molecular and cellular cardiology · 2024
    Review
  9. Article
  10. Therapeutic advances in atrial fibrillation based on animal models.Journal of Zhejiang University. Science. B · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Atrial Myopathy Underlying Atrial Fibrillation.Arrhythmia & electrophysiology review · 2020
    Review
  20. Doxycycline Improves Fibrosis-Induced Abnormalities in Atrial Conduction and Vulnerability to Atrial Fibrillation in Chronic Intermittent Hypoxia Rats.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 1 country.

Irina A Polejaeva *Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Ravi Ranjan *CARMA Center, Division of Cardiology, University of Utah, Salt Lake City, UT.
Christopher J DaviesDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Misha RegouskiDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Justin HallDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Aaron L OlsenDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Qinggang MengDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Heloisa M RutiglianoDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Derek J DosdallCenter for Engineering Innovation, University of Utah, Salt Lake City, UT.
Nathan A AngelCARMA Center, Division of Cardiology, University of Utah, Salt Lake City, UT.
Frank B SachseNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT.
Thomas SeidelNora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT.
Aaron J ThomasDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Rusty StottDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Kip E PanterUSDA ARS Poisonous Plant Research Laboratory, Logan, UT.
Pamela M LeeCollege of Veterinary Medicine, Washington State University, Pullman, WA.
Arnaud J Van WettereDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
John R StevensDepartment of Mathematics and Statistics, Utah State University, Logan, UT.
Zhongde WangDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Rob S MacLeodCARMA Center, Division of Cardiology, University of Utah, Salt Lake City, UT.
Nassir F MarroucheCARMA Center, Division of Cardiology, University of Utah, Salt Lake City, UT.
Kenneth L WhiteDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT.
Utah State University · USUniversity of Utah · USUniversity of Utah Hospital · USPoisonous Plant Research Laboratory · USWashington State University · US

Funding

His-Purkinje Pacing for Low Energy Implantable Cardioverter DefibrillatorsR01HL128752 · NHLBI · UNIVERSITY OF UTAH · PI DOSDALL, DEREK J · 2015 to 2024
$5.0M
MRI-based visualization and acute targeting of gaps in atrial ablation lesionsK23HL115084 · NHLBI · UNIVERSITY OF UTAH · PI RANJAN, RAVI · 2012 to 2016
$754k
NHLBI NIH HHS K23 HL115084NHLBI NIH HHS R01 HL128752
6 · The paper itself

Abstract

introductionLarge animal models of progressive atrial fibrosis would provide an attractive platform to study relationship between structural and electrical remodeling in atrial fibrillation (AF). Here we established a new transgenic goat model of AF with cardiac specific overexpression of TGF-β1 and investigated the changes in the cardiac structure and function leading to AF. METHODS AND

resultsTransgenic goats with cardiac specific overexpression of constitutively active TGF-β1 were generated by somatic cell nuclear transfer. We examined myocardial tissue, ECGs, echocardiographic data, and AF susceptibility in transgenic and wild-type control goats. Transgenic goats exhibited significant increase in fibrosis and myocyte diameters in the atria compared to controls, but not in the ventricles. P-wave duration was significantly greater in transgenic animals starting at 12 months of age, but no significant chamber enlargement was detected, suggesting conduction slowing in the atria. Furthermore, this transgenic goat model exhibited a significant increase in AF vulnerability. Six of 8 transgenic goats (75%) were susceptible to AF induction and exhibited sustained AF (>2 minutes), whereas none of 6 controls displayed sustained AF (P < 0.01). Length of induced AF episodes was also significantly greater in the transgenic group compared to controls (687 ± 212.02 seconds vs. 2.50 ± 0.88 seconds, P < 0.0001), but no persistent or permanent AF was observed.

conclusionA novel transgenic goat model with a substrate for AF was generated. In this model, cardiac overexpression of TGF-β1 led to an increase in fibrosis and myocyte size in the atria, and to progressive P-wave prolongation. We suggest that these factors underlie increased AF susceptibility.

Indexed as

Atrial RemodelingAction PotentialsAnimalsAnimals, Genetically ModifiedAtrial FibrillationBiopsyEchocardiographyElectrocardiographyFibrosisGenetic Predisposition to DiseaseGoatsHeart AtriaHeart RateHumansMicroscopy, ConfocalPhenotypeTGFB1 protein, humanTransforming Growth Factor beta1atrial fibrillationfibrosisgeneticsTGF-β1 transgenic goat model

Identifiers

PMID27447370
PMCPMC5065395
OpenAlexW2483522375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.